For optimal 1-year results, in patients with prior coronary artery bypass grafting who need percutaneous coronary ...
PARTNER 3 may notch a win for transcatheter aortic valve replacement in patients with low surgical risk, according to experts ...
Today’s cardiology leaders are navigating an era of strategic growth, innovation and access expansion. With shifting procedure sites, workforce constraints and reimbursement dynamics, cardiology ...
After percutaneous coronary intervention (PCI), dual antiplatelet therapy (DAPT) is recommended for 6 months in stable coronary artery disease1,2 and 12 months in acute coronary syndromes.3,4 Over the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback